Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study

doi:10.3748/wjg.v27.i17.2025

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6030)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

465

WORD

187

HTML

3220

Figures (1-3)

556

Tables (1-4)

263

Sum=4691

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

416

Download

923

Sum=1339

May 7, 2021 (publication date) through Nov 18, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. May 7, 2021; 27(17): 2025-2038
Published online May 7, 2021. doi: 10.3748/wjg.v27.i17.2025

Open in New Tab Full Size Figure Download Figure

Figure 1 Distribution of alpha-fetoprotein levels in patients without hepatocellular carcinoma. AFP: Alpha-fetoprotein; HCC: Hepatocellular carcinoma.

Open in New Tab Full Size Figure Download Figure

Figure 2 Distribution of alpha-fetoprotein level in patients with hepatocellular carcinoma. AFP: Alpha-fetoprotein; HCC: Hepatocellular carcinoma.

Open in New Tab Full Size Figure Download Figure

Figure 3 Receiver operating characteristic curve analysis of alpha-fetoprotein to diagnose hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis receiving nucleos(t)ide analog therapy. ROC: Receiver operating characteristic.

Citation: Yang DH, Wang WP, Zhang Q, Pan HY, Huang YC, Zhang JJ. Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study. World J Gastroenterol 2021; 27(17): 2025-2038
URL: https://www.wjgnet.com/1007-9327/full/v27/i17/2025.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i17.2025